You are here

OTC medicines

6 August 2021
The public consultation for the Proposed changes to Required Advisory Statements for Medicine Labels (Chlorhexidine, hydrocortisone, ibuprofen) is now open.
6 August 2021
The public consultation for the Proposed changes to Required Advisory Statements for Medicine Labels (Mometasone) is now open.
6 August 2021
The public consultation for the Proposed changes to Required Advisory Statements for Medicine Labels (Triptans) is now open.
6 August 2021
The public consultation for the Proposed changes to Required Advisory Statements for Medicine Labels (Melatonin) is now open.
20 July 2021
The TGA no longer allocates proprietary ingredient numbers to certain categories of ingredient mixtures.
6 April 2021
The TGA is seeking feedback on proposed advisory statements for OTC medicines containing menthol for inclusion in RASML. Closing date: 18 May 2021
6 April 2021
The TGA is seeking feedback on proposed advisory statements for OTC medicines containing sedating antihistamines for inclusion in RASML. Closing date: 18 May 2021
6 April 2021
The TGA is seeking feedback on proposed advisory statements for OTC medicines containing lidocaine (lignocaine) for inclusion in RASML. Closing date: 18 May 2021
6 April 2021
The TGA is seeking feedback on proposed advisory statements for OTC medicines containing methyl salicylate for inclusion in RASML. Closing date: 18 May 2021
13 January 2021
TGA is seeking feedback on a proposal to streamline how information about certain therapeutic goods formulations is entered into TGA electronic systems when seeking market approval. Closing date: 24 February 2021

Pages

Subscribe to OTC medicines